Thrombin Activates Nuclear Factor-κB and Potentiates Endothelial Cell Activation by TNF

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5620-5628

  Anrather, Dorothea ^a   Millan, Maria T ^a   Palmetshofer, Alois ^a   Robson, Simon C ^a   Geczy, Carolyn ^a   Ritchie, Andrew J ^b   Bach, Fritz H ^a   Ewenstein, Bruce M ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBIN; THROMBIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; SWINE; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELLS, CULTURED; DRUG SYNERGISM; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; NF-KAPPA B; RECEPTORS, THROMBIN; SWINE; THROMBIN; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0031306802     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Pober, J. S., and R. S. Cotran. 1990. The role of endothelial cells in inflammation. Transplantation 50:537.
2. Bach, F. H., S. C. Robson, C. Ferran, H. Winkler, M. T. Millan, K. M. Stuhlmeier, B. Vanhove, M. L. Blakeley, W. J. van der Werf, E. Hofer, R. de Martin, and W. W. Hancock. 1994. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol. Rev. 141:5.
3. Jaffe, E. A., J. Grulich, B. B. Weksler, G. Hampel, and K. Watanabe. 1987. Correlation between thrombin-induced prostacyclin production and inositol trisphosphate and cytosolic free calcium levels in cultured human endothelial cells. J. Biol. Chem. 262:8557.
4. Whatley, R. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1990. Lipid metabolism and signal transduction in endothelial cells. Prog. Lipid Res. 29:45.
5. Birch, K. A., J. S. Pober, G. B. Zavoico, A. R. Means, and B. M. Ewenstein. 1992. Calcium/calmodulin transduced thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells. J. Cell Biol. 118:1501.
6. 2+ in the secretion of von Willebrand factor from human vascular endothelial cells. Biochem. J. 286:631.
7. Malik, A. B., and J. W. Fenton. 1992. Thrombin-mediated increase in vascular endothelial permeability. Semin. Thromb. Hemost. 18:193.
8. Himmel, H. M., A. R. Whorton, and H. C. Strauss. 1993. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension 21:112.
9. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
10. Iademarco, M. F., J. J. Mcquillan, G. D. Rosen, and D. C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16321.
11. Voraberger, G., R. Schafer, and C. Stratowa. 1991. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: induction by cytokines and phorbol ester. J. Immunol. 147:2777.
12. Whelan, J., P. Ghersa, R. Hooft van Huijsduijnen, J. Gray, G. Chandra, F. Talabot, and J. F. DeLamarter. 1991. An NF-kappa B-like factor is essential but not sufficient for cytokine induction of endothelial adhesion molecule-1 (ELAM-1). Nucleic Acids. Res. 19:2645.
13. de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F. H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J. 12:2773.
14. Stein, B., and A. S. Baldwin. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol. Cell. Biol. 13:7191.
15. Cheng, Q., C. A. Cant, T. Moll, R. Hofer-Warbinek, E. Wagner, M. L. Birnstel, F. H. Bach, and R. de Martin. 1994. NF-kappa B subunit-specific regulation of the 1 kappa B α promoter. J. Biol. Chem. 269:13551.
16. Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways, and J. G. Gray. 1994. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site. J. Immunol. 153:712.
17. Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, S. Kawamoto, Y. Ishigatsubo, and T. Okubo. 1994. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:2052.
18. Marui, N., M. K. Offermann, R. Swerlick, C. Kunsch, C. A. Rosen, M. Ahmad, R. W. Alexander, and R. M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866.
19. Collins, T., M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899.
20. Resnick, N., and M. A. Gimbrone. 1995. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 9:874.
21. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell. Biol. 5:477.
22. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Ret. Cell. Biol. 10:405.
23. Thanos, D., and T. Maniatis. 1995. NF-kappa B: a lesson in family values. Cell 80:529.
24. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa BA kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723.
25. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. J. Baldwin. 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899.
26. Beg, A. A., and A. J. Baldwin. 1993. The 1 kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064.
27. Ferran, C., M. T. Millan, V. Csizmadia, J. T. Cooper, C. Brostjan, F. H. Bach, and H. Winkler. 1995. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun. 214:212.
28. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of 1 kappa B-α is necessary for activation of transcription factor NF-kappa B. Nature 365:182.
29. Fenton, J. W., F. A. Ofosu, D. G. Moon, and J. M. Maraganore. 1991. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagul. Fibrinolysis 2:69.
30. Shankar, R., C. A. de la Motte, E. J. Poptic, and P. E. DiCorleto. 1994. Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269:13936.
31. Kitazumi, K., and K. Tasaka. 1993. The role of c-Jun protein in thrombin-stimulated expression of preproendothelin-1 mRNA in porcine aortic endothelial cells. Biochem. Pharmacol. 46:455.
32. Brox, J. H., B. Osterud, E. Bjorklid, and J. W. Fenton. 1984. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br. J. Haematol. 57:239.
33. Sugama, Y., C. Tiruppathi, K, Janakidevi, T. T. Andersen, J. W. Fenton, and A. B. Malik. 1992. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119:935.
34. Gelehrter, T. D., and R. Sznycer-Laszuk. 1986. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J. Clin. Invest. 77:165.
35. Colotta, F., F. L. Sciacca, M. Sironi, W. Luini, M. J. Rabiet, and A. Mantovani. 1994. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am. J. Pathol. 144:975.
36. Kaplanski, G., M. Fabrigoule, V. Boulay, C. A. Dinarello, P. Bongrand, S. Kaplanski, and C. Farnarier. 1997. Thrombin induces endothelial type II activation in vitro. IL-1 and TNF-α-independent IL-8 secretion and E-selectin expression. J. Immunol. 158:5435.
37. Coughlin, S. R. 1994. Molecular mechanisms of thrombin signaling. Semin. Hematol. 31:270.
38. Ishihara, H., A. J. Connolly, D. Zeng, M. L. Kahn, Y. W. Zheng, C. Timmons, T. Tram, and S. R. Coughlin. 1997. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502.
39. Ngaiza, J. R., and E. A. Jaffe. 1991. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem. Biophys. Res. Commun. 179:1656.
40. Birch, K. A., B. M. Ewenstein, D. E. Golan, and J. S. Pober. 1994. Prolonged peak elevations in cytoplasmic free calcium ions, derived from intracellular stores, correlate with the extent of thrombin-stimulated exocytosis in single human umbilical vein endothelial cells. J. Cell. Physiol. 160:545.
41. Jenkins, A. L., M. D. Bootman, M. J. Berridge, and S. R. Stone. 1994. Differences in intracellular calcium signaling after activation of the thrombin receptor by thrombin and agonist peptide in osteoblast-like cells. J. Biol. Chem. 269:17104.
42. Vouret-Craviari, V., E. Obberghen-Schilling, U. B. Rasmussen, A. Pavirani, J.-P. Lecocq, and J. Pouysségur. 1992. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol. Biol. Cell 3:95.
43. Nawroth, P. P., and D. M. Stern. 1986. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163:740.
44. Scarpati, E. M., and J. E. Sadler. 1989. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J. Biol. Chem. 264:20705.
45. Hancock, W. W., M. L. Blakely, W. van der Werf, and F. H. Bach. 1993. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transplant. Proc. 25:2932.
46. Jurd, K. M., R. V. Gibbs, and B. J. Hunt. 1996. Activation of human prothrombin by porcine aortic endothelial cells: a potential barrier to pig to human xenotransplantation. Blood Coagul. Fibrinolysis 7:336.
47. Stuhlmeier, K. M., V. Csizmadia, Q. Cheng, H. Winkler, and F. H. Bach. 1994. Selective inhibition of E-selectin, ICAM-1, and VCAM in endothelial cells. Eur. J. Immunol. 24:2186.
48. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
49. Bhatia, P., W. R. Taylor, A. H. Greenberg, and J. A. Wright. 1994. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Anal. Biochem. 216:223.
50. Dingham, J. D., R. M. Lebowitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
51. Garner, M. M., and A. Revzin. 1981. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:3047.
52. Brostjan, C., J. Anrather, V. Csizmadia, G. Natarajan, F. H. Bach, and H. Winkler. 1996. Deletion analysis of the porcine E-selectin promoter. Transplant. Proc. 28:639.
53. Cooper, J. T., D. M. Stroka, C. Crostjan, A. Palmetshofer, F. H. Bach, and C. Ferran. 1996. A20 blocks endothelial cell activation through a NF-kappa-B-dependent mechanism. J. Biol. Chem. 271:18068.
54. Brostjan, C., J. Anrather, V. Csizmadia, G. Natarajan, and H. Winkler. 1997. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/ c-Jun. J. Immunol. 158:3838.
55. Hooft van Huijsduijnen, R., R. Pescini, and J. F. DeLamarter. 1993. Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element. Nucleic Acids Res. 21:3711.
56. Schindler, U., and V. R. Baichwal. 1994. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell. Biol. 14:5820.
57. Marsen, T. A., M. S. Simonson, and M. J. Dunn. 1995. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ. Res. 76:987.
58. Read, M. A., M. Z. Whitley, A. J. Williams, and T. Collins. 1994. NF-kappa B and I kappa Bα: an inducible regulatory system in endothelial activation. J. Exp. Med. 179:503.
59. Mari, B., V. Imbert, N. Belhacene, D. F. Far, J. F. Peyron, J. Pouyssegur, E. Van Obberghen-Schilling, B. Rossi, and P. Auberger. 1994. Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin-2 production. J. Biol. Chem. 269:8517.
60. Nakajima, T., I. Kitajima, H. Shin, I. Takasaki, K. Shigeta, K. Abeyama, Y. Yamashita, T. Tokioka, Y. Soejima, and I. Maruyama. 1994. Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 204:950.
61. Stein, B., A. S. Baldwin, D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879.
62. Scarpati, E. M., and P. E. DiCorleto. 1996. Identification of a thrombin response element in the human platelet-derived growth factor B-chain (c-sis) promoter. J. Biol. Chem. 271:3025.
63. Rothe, M., V. Sasrma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424.
64. Hsu, H., H.-B. Shu, M.-G. Pan, and D. V. Goedell. 1996. TRADD-TRAF2 and TRAD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways. Cell 84:299.
65. Hsu, H., J. Huang, H.-B. Shu, V. Baichwal, and D. V. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387.
66. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF kappa B induction by TNF, CD95 and IL-1. Nature 385:540.
67. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an I kappa B kinase. Cell 90:373.
68. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853.
69. Diaz-Meco, M. T., I. Dominguez, L. Sanz, P. Dent, J. Lozano, M. M. Municio, E. Berra, R. T. Hay, T. W. Sturgill, and J. Moscat. 1994. Zeta PKC induces phosphorylation and inactivation of I kappa B-α in vitro. EMBO J. 13:2842.
70. Diaz-Meco, M. T., E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M. T. Lain de Lera, J. Alcamí, C. V. Payá, F. Arenzana-Seisdedos, J.-L. Virelizier, and J. Moscat. 1993. A dominant negative protein kinase C zeta subspecies blocks NF kappa B activation. Mol. Cell. Biol. 13:4770.
71. Schouten, G. J., A. C. O. Vertegaal, S. T. Whiteside, A. Israel, M. Toebes, J. C. Dorsman, A. J. van der Eb, and A. Zantema. 1997. I kappa B-alpha is a target for the mitogen-activated 90 kDa ribosomal s6 kinase. EMBO J. 16:3133.
72. Bennett, B. L., R. G. Lacson, C. C. Chen, R. Cruz, J. S. Wheeler, R. F. Kletzien, A. G. Tomasselli, R. L. Heinrikson, and A. M. Manning. 1996. Identification of signal-induced I kappa B-alpha kinases in human endothelial cells. J. Biol. Chem. 271:19680.
73. Haller, H., W. Ziegler, C. Lindschau, and F. C. Luft. 1996. Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler. Thromb. 16:678.
74. Tseng, C. P., Y. J. Kim, R. Kumar, and A. K. Verma. 1995. Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol-13-acetate-inducible genes modulated by AP-1 or non-AP-1 transacting factors. Carcinogenesis 15:707.
75. Wheeler-Jones, C. P. D., M. J. May, R. A. Houliston, and J. D. Pearson. 1996. Inhibition of MAP kinase kinase (MEK) blocks endothelial PGI2 release but has no effect on von Willebrand factor secretion or E-selectin expression. FEBS Lett. 388:180.
76. Sturgill, T. W., L. B. Ray, E. Erikson, and J. L. Maller. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715.
77. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
78. Bevilacqua, M. P., J. S. Pober, G. R. Majeau, W. Fiers, R. S. Cotran, and M. A. Gimbrone. 1986. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA 83:4533.
79. Mulder, A. B., K. S. M. Hegge-Paping, C. P. E. Magielse, N. R. Blom, J. W. Smith, J. van der Meer, M. R. Halie, and V. J. J. Born. 1994. Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood 84:1559.
80. Conway, E. M., and R. D. Rosenberg. 1988. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell. Biol. 8:5588.
81. Hooper, W. C., D. J. Phillips, M. J. A. Ribeiro, J. M. Benson, V. G. George, E. W. Ades, and B. L. Evatt. 1994. Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood 84:483.
82. Robson, S. C., E. Kaczmarek, J. B. Siegel, D. Candinas, K. Koziak, M. Millan, W. W. Hancock, and F. H. Bach. 1997. Loss of ATP diphosphohydrolase (ATPDase) activity with endothelial cell activation. J. Exp. Med. 185:153.
83. Liu, L., and G. M. Rodgers. 1996. Characterization of an inducible endothelial cell prothrombin activator. Blood 88:2989.
84. Bauer, K. A., H. tenCate, S. Barzegar, D. R. Spriggs, M. L. Sherman, and R. D. Rosenberg. 1989. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74:165.
85. Robson, S. C., V. K. Young, N. S. Cook, R. Metternich, W. Kasper-Kong, B. A. Lesnikoski, R. N. Pierson, W. W. Hancock, D. Candinas, D. J. White, and F. H. Bach. 1996. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 61:862.